Lockheed Martin Corporation vs Vertex Pharmaceuticals Incorporated
Market cap comparison over time
Lockheed Martin Corporation
$135.2B
Rank #124
Vertex Pharmaceuticals Incorporated
$136.4B
Rank #122
Market Cap Over Time
Key Moments
- Vertex Pharmaceuticals Incorporated overtook Lockheed Martin Corporation by 1996
- Lockheed Martin Corporation overtook Vertex Pharmaceuticals Incorporated by 1997
- Vertex Pharmaceuticals Incorporated overtook Lockheed Martin Corporation by 1999
- Lockheed Martin Corporation overtook Vertex Pharmaceuticals Incorporated by 2002
- Vertex Pharmaceuticals Incorporated overtook Lockheed Martin Corporation by 2009
- Lockheed Martin Corporation overtook Vertex Pharmaceuticals Incorporated by 2010
- Vertex Pharmaceuticals Incorporated overtook Lockheed Martin Corporation by 2023
- Lockheed Martin Corporation overtook Vertex Pharmaceuticals Incorporated by 2024
- Vertex Pharmaceuticals Incorporated overtook Lockheed Martin Corporation by 2025
Year-by-Year Comparison
| Year | Lockheed Martin Corporation | Vertex Pharmaceuticals Incorporated | Leader |
|---|---|---|---|
| 2026 | $135.2B | $136.4B | Vertex Pharmaceuticals Incorporated |
| 2025 | $109.4B | $115.1B | Vertex Pharmaceuticals Incorporated |
| 2024 | $106.9B | $102.2B | Lockheed Martin Corporation |
| 2023 | $97.8B | $103.3B | Vertex Pharmaceuticals Incorporated |
| 2022 | $102.2B | $73.3B | Lockheed Martin Corporation |
| 2021 | $72.7B | $55.7B | Lockheed Martin Corporation |
| 2020 | $70.5B | $60.0B | Lockheed Martin Corporation |
| 2019 | $75.4B | $55.6B | Lockheed Martin Corporation |
| 2018 | $49.4B | $42.1B | Lockheed Martin Corporation |
| 2017 | $59.1B | $38.0B | Lockheed Martin Corporation |
| 2016 | $44.8B | $18.7B | Lockheed Martin Corporation |
| 2015 | $37.9B | $31.9B | Lockheed Martin Corporation |
| 2014 | $32.6B | $30.2B | Lockheed Martin Corporation |
| 2013 | $24.4B | $18.9B | Lockheed Martin Corporation |
| 2012 | $14.5B | $10.6B | Lockheed Martin Corporation |
| 2011 | $12.1B | $8.4B | Lockheed Martin Corporation |
| 2010 | $10.1B | $8.9B | Lockheed Martin Corporation |
| 2009 | $10.5B | $10.9B | Vertex Pharmaceuticals Incorporated |
| 2008 | $11.3B | $7.7B | Lockheed Martin Corporation |
| 2007 | $13.9B | $5.9B | Lockheed Martin Corporation |
| 2006 | $12.0B | $9.5B | Lockheed Martin Corporation |
| 2005 | $8.1B | $7.0B | Lockheed Martin Corporation |
| 2004 | $7.0B | $2.7B | Lockheed Martin Corporation |
| 2003 | $6.4B | $2.6B | Lockheed Martin Corporation |
| 2002 | $7.1B | $4.0B | Lockheed Martin Corporation |
| 2001 | $5.7B | $6.2B | Vertex Pharmaceuticals Incorporated |
| 2000 | $4.1B | $18.1B | Vertex Pharmaceuticals Incorporated |
| 1999 | $2.6B | $4.4B | Vertex Pharmaceuticals Incorporated |
| 1998 | $4.9B | $3.8B | Lockheed Martin Corporation |
| 1997 | $5.6B | $4.2B | Lockheed Martin Corporation |
| 1996 | $5.1B | $5.1B | Vertex Pharmaceuticals Incorporated |
| 1995 | $4.3B | $3.4B | Lockheed Martin Corporation |
| 1994 | $2.4B | $1.9B | Lockheed Martin Corporation |